Effects of <i>Piper sarmentosum</i> on Metabolic Syndrome and Its Related Complications: A Review of Preclinical Evidence

<i>Piper sarmentosum</i> (PS) is a traditional medicinal herb used by South East Asians. It demonstrates promising properties against various non-communicable diseases and infectious agents due to its antioxidant and anti-inflammatory properties. Given that oxidative stress and inflammat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sophia Ogechi Ekeuku, Mohd Fahami Nur Azlina, Kok-Yong Chin
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
T
Acceso en línea:https://doaj.org/article/d9228941723643019ea0f56bbfa66a17
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d9228941723643019ea0f56bbfa66a17
record_format dspace
spelling oai:doaj.org-article:d9228941723643019ea0f56bbfa66a172021-11-11T14:59:33ZEffects of <i>Piper sarmentosum</i> on Metabolic Syndrome and Its Related Complications: A Review of Preclinical Evidence10.3390/app112198602076-3417https://doaj.org/article/d9228941723643019ea0f56bbfa66a172021-10-01T00:00:00Zhttps://www.mdpi.com/2076-3417/11/21/9860https://doaj.org/toc/2076-3417<i>Piper sarmentosum</i> (PS) is a traditional medicinal herb used by South East Asians. It demonstrates promising properties against various non-communicable diseases and infectious agents due to its antioxidant and anti-inflammatory properties. Given that oxidative stress and inflammation are involved in developing and exacerbating metabolic syndrome (MetS) and its principal components (central obesity, hyperglycaemia, hypertension, and dyslipidaemia), PS could manage MetS and its complications. This review summarises the available literature on the effects of PS on principal components of MetS and their complications. The accumulated evidence suggests that PS prevented adiposity, hyperglycaemia, hypertension, and dyslipidaemia in preclinical studies mainly through its antioxidant and anti-inflammatory properties. It also protected against MetS-associated cardiovascular complications. This review has identified research gaps in this field and suggested future studies to guide interested researchers to explore further or affirm the therapeutic potential of PS. One of the most significant challenges to the medical use of PS is the absence of randomised controlled trials in humans. This study gap must be bridged before PS supplementation could be used to manage MetS in humans.Sophia Ogechi EkeukuMohd Fahami Nur AzlinaKok-Yong ChinMDPI AGarticlecholesterolinflammationoxidative stresshypertensionobesitydiabetesTechnologyTEngineering (General). Civil engineering (General)TA1-2040Biology (General)QH301-705.5PhysicsQC1-999ChemistryQD1-999ENApplied Sciences, Vol 11, Iss 9860, p 9860 (2021)
institution DOAJ
collection DOAJ
language EN
topic cholesterol
inflammation
oxidative stress
hypertension
obesity
diabetes
Technology
T
Engineering (General). Civil engineering (General)
TA1-2040
Biology (General)
QH301-705.5
Physics
QC1-999
Chemistry
QD1-999
spellingShingle cholesterol
inflammation
oxidative stress
hypertension
obesity
diabetes
Technology
T
Engineering (General). Civil engineering (General)
TA1-2040
Biology (General)
QH301-705.5
Physics
QC1-999
Chemistry
QD1-999
Sophia Ogechi Ekeuku
Mohd Fahami Nur Azlina
Kok-Yong Chin
Effects of <i>Piper sarmentosum</i> on Metabolic Syndrome and Its Related Complications: A Review of Preclinical Evidence
description <i>Piper sarmentosum</i> (PS) is a traditional medicinal herb used by South East Asians. It demonstrates promising properties against various non-communicable diseases and infectious agents due to its antioxidant and anti-inflammatory properties. Given that oxidative stress and inflammation are involved in developing and exacerbating metabolic syndrome (MetS) and its principal components (central obesity, hyperglycaemia, hypertension, and dyslipidaemia), PS could manage MetS and its complications. This review summarises the available literature on the effects of PS on principal components of MetS and their complications. The accumulated evidence suggests that PS prevented adiposity, hyperglycaemia, hypertension, and dyslipidaemia in preclinical studies mainly through its antioxidant and anti-inflammatory properties. It also protected against MetS-associated cardiovascular complications. This review has identified research gaps in this field and suggested future studies to guide interested researchers to explore further or affirm the therapeutic potential of PS. One of the most significant challenges to the medical use of PS is the absence of randomised controlled trials in humans. This study gap must be bridged before PS supplementation could be used to manage MetS in humans.
format article
author Sophia Ogechi Ekeuku
Mohd Fahami Nur Azlina
Kok-Yong Chin
author_facet Sophia Ogechi Ekeuku
Mohd Fahami Nur Azlina
Kok-Yong Chin
author_sort Sophia Ogechi Ekeuku
title Effects of <i>Piper sarmentosum</i> on Metabolic Syndrome and Its Related Complications: A Review of Preclinical Evidence
title_short Effects of <i>Piper sarmentosum</i> on Metabolic Syndrome and Its Related Complications: A Review of Preclinical Evidence
title_full Effects of <i>Piper sarmentosum</i> on Metabolic Syndrome and Its Related Complications: A Review of Preclinical Evidence
title_fullStr Effects of <i>Piper sarmentosum</i> on Metabolic Syndrome and Its Related Complications: A Review of Preclinical Evidence
title_full_unstemmed Effects of <i>Piper sarmentosum</i> on Metabolic Syndrome and Its Related Complications: A Review of Preclinical Evidence
title_sort effects of <i>piper sarmentosum</i> on metabolic syndrome and its related complications: a review of preclinical evidence
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/d9228941723643019ea0f56bbfa66a17
work_keys_str_mv AT sophiaogechiekeuku effectsofipipersarmentosumionmetabolicsyndromeanditsrelatedcomplicationsareviewofpreclinicalevidence
AT mohdfahaminurazlina effectsofipipersarmentosumionmetabolicsyndromeanditsrelatedcomplicationsareviewofpreclinicalevidence
AT kokyongchin effectsofipipersarmentosumionmetabolicsyndromeanditsrelatedcomplicationsareviewofpreclinicalevidence
_version_ 1718437932292898816